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=Abstract=With the widespread use of gonadotropin-releasing hormone agonist
(GnRH-a) for in vitro fertilization(IVF) program, the cancellation rate during controlled
ovarian hyperstimulation(COH} is much lowered. However, poor responders with poor
estradioI(E2} rise or single dominant follicle still persist in GnRH-a combined COH,
and the decision to cancel the cycle and the counselling of further cycles remain very
perplexing. Three poor responders with single dominant follicle during GnRH-a
combined COH for IVF were, rather than being cancelled, managed by continuous
administration of GnRH-a and restimulation with initial low dosage and subsequent
high dosage of follicle-stimulating hormone until an appropriate number of follicles was
obtained. While no pregnant case treated in this way, the management resulted in a
higher E2 level, and more oocytes and embryos. We suggest that this approach could
serve as an alternative to cancellation in GnRH-a combined COHo
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INTRODUCTION
Recently the use of gonadotropin-releas-
ing hormone agonist(GnRH-a) has been fre-
quently indicated in controlled ovarian hyper-
stimulation(COH) for in vitro fertilization (IVF)
program and satisfactory results have been
obtained in terms of the cancellation and
pregnancy rates (Katavama et a/. 1988;
Serafini et al. 1988; Droesch et al. 1990).
Poor responders, especially with poor
Received January 1992, and in final form March
1992.
;"1 4 r ll i51- ;-;/ 01 ;7] rlli51- A)..!';!-0l ~,1 8'1- ~I /-1 . 71 A-l~
t L-fl .......,...L-L-- ~..LJ L-fl --, '-.....:. , L.:....l-'-f -, J...L- 2. . 0 --, l.......:.,
estradiol(E2) rise or single dominant follicle, are
a particularly challenging group of patients
encountered in COHo At present, except for an
oocytes donation program, COH with GnRH-a
is the last resort for poor responders. Even
though the cancellation rate is low, cancelled
cases persist in the GnRH-a combined COH
and the main reason for cancellation is the
growth of fewer follicles(Porter et al. 1984;
Meldrum et al. 1989). When using the GnRH-a
combined COH, the decision to cancel the
cycle is difficult and counselling of further
cycles in these patients is even more difficult.
As we have experienced rather successful man-
agement of single dominant follicle during the
GnRH-a combined COH with the continuous
administration of GnRH-a followed by high




